Virtual Screening in Drug Discovery

Drug Discovery Research: New Frontiers in the Post-Genomic Era

Volumn , Issue , 2006, Pages 63-88

  McGregor, Malcolm J ^a   Luo, Zhaowen ^a   Jiang, Xuliang ^a  

^a Serono Research Institute   (United States)

Author keywords

Compound collection maintenance; Target dependent methods; Virtual screening in drug discovery

Indexed keywords

EID: 84889387512     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470131862.ch3     Document Type: Chapter

References (138)

1. Anstead, G. M., Carlson, K. E., and Katzenellenbogen, J. A. (1997). The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62, 268-303.
2. Arnold, J. R., Burdick, K.W., Pegg, S. C., Toba, S., Lamb, M. L., and Kuntz, I. D. (2004). SitePrint: Threedimensional pharmacophore descriptors derived from protein binding sites for family based active site analysis, classification, and drug design. J Chem Inf Comput Sci 44, 2190-2198.
3. Bajorath, J. (2002). Integration of virtual and high-throughput screening. Nat Rev Drug Discov 1, 882-894.
4. Barnum, D., Greene, J., Smellie, A., and Sprague, P. (1996). Identification of common functional configurations among molecules. J Chem Inf Comput Sci 36, 563-571.
5. Bissantz, C., Folkers, G., and Rognan, D. (2000). Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J Med Chem 43, 4759-4767.
6. Bissantz, C., Bernard, P., Hibert, M., and Rognan, D. (2003). Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? Proteins 50, 5-25.
7. Blake, J. E., Famer, N. A., and Haines, R. C. (1977).An interactive computer graphics system for processing chemical structure diagrams. J Chem Inf Comput Sci 17, 223-228.
8. Blake, J. F. (2004). Integrating cheminformatic analysis in combinatorial chemistry. Curr Opin Chem Biol 8, 407-411.
9. Bohm, H. J. (1994). The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput Aided Mol Des 8, 243-256.
10. Bondensgaard, K., Ankersen, M., Thogersen, H., Hansen, B. S., Wulff, B. S., and Bywater, R. P. (2004).
11. Bossemeyer, D., Engh, R. A., Kinzel, V., Ponstingl, H., and Huber, R. (1993). Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2{thorn} adenylyl imidodiphosphate and inhibitor peptide PKI(5-24). EMBO J 12, 849-859.
12. Brown, R., and Martin, Y. (1996). Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J Chem Inf Comput Sci 36, 572-584.
13. Cavasotto, C. N., and Abagyan, R. A. (2004). Protein flexibility in ligand docking and virtual screening to protein kinases. J Mol Biol 337, 209-225.
14. Charifson, P. S., Corkery, J. J., Murcko, M. A., andWalters,W. P. (1999). Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem 42, 5100-5109.
15. Chen, X., Rusinko III, A., and Young, S. S. (1998). Recursive partitioning analysis of a large structure-activity data set using three-dimenstional descriptors. J Chem Inf Comput Sci 38, 1054-1062.
16. Chuaqui, C., Deng, Z., and Singh, J. (2005). Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening. J Med Chem 48, 121-133.
17. Clark, D. E. (1999a). Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J Pharm Sci 88, 807-814.
18. Clark, D. E. (1999b). Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci 88, 815-821.
19. Cramer, R. D., III, Patterson, D. E., and Bunce, J. D. (1988). Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110, 5959-5967.
20. Cronin, M. T., Jaworska, J. S.,Walker, J. D., Comber,M. H.,Watts, C. D., andWorth, A. P. (2003). Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environ Health Perspect 111, 1391-1401.
21. Cruciani, G., Pastor, M., and Guba,W. (2000).VolSurf:Anewtool for the pharmacokinetic optimization of lead compounds. Eur J Pharm Sci 11 (Suppl 2), S29-S39.
22. Cummings, M. D., DesJarlais, R. L., Gibbs, A. C., Mohan, V., and Jaeger, E. P. (2005). Comparison of automated docking programs as virtual screening tools. J Med Chem 48, 962-976.
23. Davis, A. M., Teague, S. J., and Kleywegt, G. J. (2003). Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. Angew Chem Int Ed Engl 42, 2718-2736.
24. Deng, Z., Chuaqui, C., and Singh, J. (2004). Structural interaction fingerprint (SIFt): A novel method for analyzing three-dimensional protein-ligand binding interactions. J Med Chem 47, 337-344.
25. Desai, P. V., Patny, A., Sabnis, Y., Tekwani, B., Gut, J., Rosenthal, P., Srivastava, A., and Avery,M. (2004).
26. Dewitte, R. S., Ishchenko, A. V., and Shakhnovich, F. I. (1997). SMoG: De novo design method on simple, fast, and accurate free energy estimates. 2. Case studies in molecular design. J Am Chem Soc 119, 4608-4617.
27. Diller, D., and Li, R. (2003). Kinases, homology models, and high throughput docking. J Med Chem 46, 4638-4647.
28. Dromey, R. G. (1978). A structural molecular formula for flexible and efficient substructure searching of large databases. J Chem Inf Comput Sci 18, 163-168.
29. Ekins, S. (2003). In silico approaches to predicting drug metabolism, toxicology and beyond. Biochem Soc Trans 31, 611-614.
30. Eldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V., and Mee, R. P. (1997). Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des 11, 425-445.
31. Enslein, K., and Craig, P. N. (1982). Carcinogenesis: a predictive structure-activity model. J Toxicol Environ Health 10, 521-530.
32. Erickson, J. A., Jalaie, M., Robertson, D., Lewis, R., and Vieth, M. (2004). Lessons in molecular recognition: The effects of ligand and protein flexibility on molecular docking accuracy. J Med Chem 47, 45-55.
33. Ertl, P., Rohde, B., and Selzer, P. (2000). Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43, 3714-3717.
34. Evers, A., and Klabunde, T. (2005). Structure-based drug discovery using GPCR homology modeling: Successful virtual screening for antagonists of the alpha1A adrenergic receptor. J Med Chem 48, 1088-1097.
35. Ewing, T., Makino, S., Skillman, A., and Kuntz, I. (2001). DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases. J Comput-Aided Mol Des 15, 411-428.
36. FDA. Challenge and Opportunity on the Critical Path to New Medical Products. 2004. U.S. Department of Health and Human Services, Food and Drug Administration.
37. Feldmann, R. J., and Heller, S. R. (1972). An application of interactive graphics-the nested retrieval of chemical structures. J Chem Inf Comput Sci 12, 48-54.
38. Feldmann, R. J., Milne, G.W. A., Heller, S. R., Fein, A., Miller, J. A., and Koch, B. (1977). An interactive substructure search system. J Chem Inf Comput Sci 17, 157-163.
39. Fernandez-Recio, J., Totrov, M., and Abagyan, R. (2002). Soft protein-protein docking in internal coordinates. Protein Sci 11, 280-291.
40. Fradera, X., Knegtel, R. M., and Mestres, J. (2000). Similarity-driven flexible ligand docking. Proteins 40, 623-636.
41. Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., and Shenkin, P. S. (2004). Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47, 1739-1749.
42. Frimurer, T. M., Bywater, R., Naerum, L., Norskov, L., and Brunak, S. (2000). Improving the odds in discriminating ''drug-like'' from ''non drug-like'' compounds. J Chem Inf Comput Sci 40, 1315-1324.
43. Gillet, V. J., Willett, P., and Bradshaw, J. (2003). Similarity searching using reduced graphs. J Chem Inf Comput Sci 43, 338-345.
44. Gobbi, A., and Lee, M. L. (2003). DISE: directed sphere exclusion. J Chem Inf Comput Sci 43, 317-323.
45. Gohlke, H., Hendlich, M., and Klebe, G. (2000). Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol 295, 337-356.
46. Good, A. C., Cheney, D. L., Sitkoff, D. F., Tokarski, J. S., Stouch, T. R., Bassolino, D. A., Krystek, S. R., Li, Y., Mason, J. S., and Perkins, T. D. (2003). Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: Mapping a pharmacophore for success. J Mol Graph Model 22, 31-40.
47. Greene, J., Kahn, S., Savoj, H., Sprague, P., and Teig, S. (1994). Chemical function queries for 3D database search. J Chem Inf Comput Sci 34, 1297-1308.
48. Grover, I. I., Singh, I. I., and Bakshi, I. I. (2000a). Quantitative structure-property relationships in pharmaceutical research-Part 1. Pharm Sci Technol Today 3, 28-35.
49. Grover, I. I., Singh, I. I., and Bakshi, I. I. (2000b). Quantitative structure-property relationships in pharmaceutical research-Part 2. Pharm Sci Technol Today 3, 50-57.
50. Hajduk, P. J., Bures, M., Praestgaard, J., and Fesik, S.W. (2000). Privileged molecules for protein binding identified from NMR-based screening. J Med Chem 43, 3443-3447.
51. Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., and Banks, J. L. (2004). Glide:Anewapproach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47, 1750-1759.
52. Hansch, C., Klein, T., McClarin, J., Langridge, R., and Cornell, N. W. (1986). A quantitative structure-activity relationship and molecular graphics analysis of hydrophobic effects in the interactions of inhibitors with alcohol dehydrogenase. J Med Chem 29, 615-620.
53. Harper, G., Bravi, G. S., Pickett, S. D., Hussain, J., and Green, D.V. (2004). The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data. J Chem Inf Comput Sci 44, 2145-2156.
54. Hawkins, D. M., Young, S. S., and Rusinko, A., III (1997). Analysis of a large structure-activity data set using recursive partitioning. Quant Struct-Act Relat 16, 296-302.
55. Henry, D. R., Jurs, P. C., and Denny, W. A. (1982). Structure-antitumor activity relationships of 9-anilinoacridines using pattern recognition. J Med Chem 25, 899-908.
56. Hindle, S. A., Rarey, M., Buning, C., and Lengaue, T. (2002). Flexible docking under pharmacophore type constraints. J Comput Aided Mol Des 16, 129-149.
57. Hodes, L. (1981). Selection of molecular fragment features for structure-activity studies in antitumor screening. J Chem Inf Comput Sci 21, 132-136.
58. Jacobsson, M., Liden, P., Stjernschantz, E., Bostrom, H., and Norinder, U. (2003). Improving structurebased virtual screening by multivariate analysis of scoring data. J Med Chem 46, 5781-5789.
59. Jiang, F., and Kim, S. H. (1991). ''Soft docking'': Matching of molecular surface cubes. J Mol Biol 219, 79-102.
60. Jones, G.,Willett, P., Glen, R., Leach, A., and Taylor, R. (1997). Development and validation of a genetic algorithm to flexible docking. J Mol Biol 267, 727-748.
61. Jorgensen, W. L. (2004). The many roles of computation in drug discovery. Science 303, 1813-1818.
62. Kennedy, T. (1997). Managing the drug discovery/development interface. Drug Discov Today 2, 436-444.
63. Kier, L. B., and Hall, L. H. (1989). Differential molecular connectivity in data-base fragment searching. Pharm Res 6, 497-500.
64. Kier, L. B., and Hall, L. H. (1990). An electrotopological-state index for atoms in molecules. Pharm Res 7, 801-807.
65. Kitchen, D. B., Decornez, H., Furr, J. R., and Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov 3, 935-949.
66. Klopman, G. (1984). Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J Am Chem Soc 106, 7315-7321.
67. Kontoyianni, M., McClellan, L., and Sokol, G. (2004). Evaluation of docking performance: Comparative data on docking algorithms. J Med Chem 47, 558-565.
68. Kubinyi, H. (1998). Combinatorial and computational approaches in structure-based drug design. Curr Opin Drug Discov Dev 1, 16-27.
69. Kubinyi, H. (2003). Drug research: Myths, hype and reality. Nat Rev Drug Discov 2, 665-668.
70. Kuntz, I., Blaney, J., Oatley, S., Langridge, R., and Ferrin, T. (1982). A geometric approach to macromolecule-ligand interactions. J Mol Biol 161, 269-288.
71. Langer, T. , andWolber, G. (2004). Pharmacophore definition and 3D searches. Drug Discov Today 1, 203-207.
72. Lewell, X. Q., Judd, D. B.,Watson, S. P., and Hann, M. M. (1998). RECAP-Retrosynthetic combinatorial analysis procedure: A powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci 38, 511-522.
73. Li, C., Xu, L., Wolan, D. W., Wilson, I. A., and Olson, A. J. (2004). Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors. J Med Chem 47, 6681-6690.
74. Lipinski, C. A., Lombardo, F., Dominy, B.W., and Fernandes, P. B. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23, 2-25.
75. Lyne, P. D., Kenny, P. W., Cosgrove, D. A., Deng, C., Zabludoff, S., Wendoloski, J. J., and Ashwell, S. (2004). Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening. J Med Chem 47, 1962-1968.
76. Martin, Y. C., Kofron, J., and Traphagen, L. M. (2003). Do structurally similar molecules have similar biological activity? J Med Chem 45, 4350-4358.
77. Mason, J. S., Morize, I., Menard, P. R., Cheney, D. L., Hulme, C., and Labaudiniere, R. F. (1999). New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. J Med Chem 42, 3251-3264.
78. Mason, J. S., Good, A. C., and Martin, E. J. (2001). 3-D pharmacophores in drug discovery. Curr Pharm Des 7, 567-597.
79. Matter, H. (1997). Selecting optimally diverse compounds from structure databases: Avalidation study of two-dimensional and three-dimensional molecular descriptors. J Med Chem 40, 1219-1229.
80. Mattioni, B. E., Kauffman, G. W., Jurs, P. C., Custer, L. L., Durham, S. K., and Pearl, G. M. (2003). Predicting the genotoxicity of secondary and aromatic amines using data subsetting to generate a model ensemble. J Chem Inf Comput Sci 43, 949-963.
81. McGovern, S. L., Caselli, E., Grigorieff, N., and Shoichet, B. K. (2002). A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 45, 1712-1722.
82. McGovern, S. L., Helfand, B. T., Feng, B., and Shoichet, B. K. (2003).Aspecific mechanism of nonspecific inhibition. J Med Chem 46, 4265-4272.
83. McGregor, M. J., and Muskal, S. M. (1999). Pharmacophore fingerprinting. 1. Application to QSAR and focused library design. J Chem Inf Comput Sci 39, 569-574.
84. McGregor, M. J., and Muskal, S. M. (2000). Pharmacophore fingerprinting. 2. Application to primary library design. J Chem Inf Comput Sci 40, 117-125.
85. McGregor, M. J., and Pallai, P. V. (1997). Clustering of large databases of compounds: Using the MDL ''keys'' as structural descriptors. J Chem Inf Comput Sci 37, 443-448.
86. Merlot, C., Domine, D., and Church, D. J. (2002). Fragment analysis in small molecule discovery. Curr Opin Drug Discov Dev 5, 391-399.
87. Merlot, C., Domine, D., Cleva, C., and Church, D. J. (2003). Chemical substructures in drug discovery. Drug Discov Today 8, 594-602.
88. Minutolo, F., Antonello, M., Bertini, S., Ortore, G., Placanica, G., Rapposelli, S., Sheng, S., Carlson, K. E., Katzenellenbogen, B. S., Katzenellenbogen, J. A., and Macchia, M. (2003). Novel estrogen receptor ligands based on an anthranylaldoxime structure: Role of the phenol-type pseudocycle in the binding process. J Med Chem 46, 4032-4042.
89. Morris, G., Goodsell, D., Halliday, R., Huey, R., Hart, W., Belew, R., and Olson, A. (2004). Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19, 1639-1662.
90. Muegge, I., Heald, S. L., and Brittelli, D. (2001). Simple selection criteria for drug-like chemical matter. J Med Chem 44, 1841-1846.
91. Muegge, I., and Martin, Y. C. (1999).A general and fast scoring function for protein-ligand interactions:A simplified potential approach. J Med Chem 42, 791-804.
92. Muller, G. (2003). Medicinal chemistry of target family-directed masterkeys. Drug Discov Today 8, 681-691.
93. Navia, M. A., and Chaturvedi, P. R. (1996). Design principles for orally bioavailable drugs. Drug Discov Today 1, 179-189.
94. Oprea, T. I., Davis, A. M., Teague, S. J., and Leeson, P. D. (2001). Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci 41, 1308-1315.
95. Oshiro, C., Bradley, E., Eksterowicz, J., Evensen, E., Lamb, M., Lanctot, J., Putta, S., Stanton, R., and Grootenhuis, D. (2004). Performance of 3D-database molecular docking studies into homology models. J Med Chem 47, 764-767.
96. Palm, K., Luthman, K., Ungell, A. L., Strandlund, G., and Artursson, P. (1996). Correlation of drug absorption with molecular surface properties. J Pharm Sci 85, 32-39.
97. Pardridge, W. M. (1995). Transport of small molecules through the blood-brain barrier: Biology and methodology. Adv Drug Deliv Rev 15, 5-36.
98. Pearl, G. M., Livingston-Carr, S., and Durham, S. K. (2001). Integration of computational analysis as a sentinel tool in toxicological assessments. Curr Top Med Chem 1, 247-255.
99. Perez, C., and Ortiz, A. R. (2001). Evaluation of docking functions for protein-ligand docking. J Med Chem 44, 3768-3785.
100. Perola, E., and Charifson, P. S. (2004). Conformational analysis of drug-like molecules bound to proteins: An extensive study of ligand reorganization upon binding. J Med Chem 47, 2499-2510.
101. Perola, E.,Walters,W. P., and Charifson, P. S. (2004).Adetailed comparison of current docking and scoring methods on systems of pharmaceutical relevance. Proteins 56, 235-249.
102. Pickett, S. D., Mason, J. S., and McLay, I. M. (1996). Diversity profiling and design using 3D pharmacophores: Pharmacophore-derived queries (PDQ). J Chem Inf Comput Sci 36, 1214-1223.
103. Rarey, M., Kramer, B., Lengauer, T., and Klebe, G. (1996). A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261, 269-288.
104. Rishton, G. M. (1997). Reactive compounds and in vitro false positives in HTS. Drug Discov Today 2, 382-384.
105. Rishton, G. M. (2003). Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov Today 8, 86-96.
106. Roche, O., Schneider, P., Zuegge, J., Guba,W., Kansy, M., Alanine, A., Bleicher, K., Danel, F., Gutknecht, E. M., Rogers-Evans, M., Neidhart, W., Stalder, H., Dillon, M., Sjogren, E., Fotouhi, N., Gillespie, P., Goodnow, R., Harris, W., Jones, P., Taniguchi, M., Tsujii, S., von der, S. W., Zimmermann, G., and Schneider, G. (2002). Development of a virtual screening method for identification of ''frequent hitters'' in compound libraries. J Med Chem 45, 137-142.
107. Sadowski, J., and Kubinyi, H. (1998). A scoring scheme for discriminating between drugs and nondrugs. J Med Chem 41, 3325-3329.
108. Salim, N., Holliday, J., andWillett, P. (2003). Combination of fingerprint-based similarity coefficients using data fusion. J Chem Inf Comput Sci 43, 435-442.
109. Sauer, W. H., and Schwarz, M. K. (2003a). Molecular shape diversity of combinatorial libraries: A prerequisite for broad bioactivity. J Chem Inf Comput Sci 43, 987-1003.
110. Sauer, W. H., and Schwarz, M. K. (2003b). Size doesn't matter: Scaffold diversity, shape diversity and biological activity of combinatorial libraries. Chimia 57, 276-283.
111. Saxberg, B. E. H., Blom, D. S., and Kowalski, B. R. (1976). A flexible interactive graphics system for searching atom connectivity matrices. J Chem Inf Comput Sci 16, 233-238.
112. Schuffenhauer, A., Floersheim, P., Acklin, P., and Jacoby, E. (2003). Similarity metrics for ligands reflecting the similarity of the target proteins. J Chem Inf Comput Sci 43, 391-405.
113. Shemetulskis, N. E., Weininger, D., Blankley, C. J., Yang, J. J., and Humblet, C. (1996). Stigmata: An algorithm to determine structural commonalities in diverse datasets. J Chem Inf Comput Sci 36, 862-871.
114. Snarey, M., Terrett, N. K.,Willett, P., andWilton, D. J. (1997). Comparison of algorithms for dissimilaritybased compound selection. J Mol Graph Model 15, 372-385.
115. Sprague, P. (1995). Automated chemical hypothesis generation and database searching with catalyst. In B. V. K. Mueller (Ed.), Perspectives in Drug Discovery and Design. Leiden: ESCOM Science Publishers, pp.1-20.
116. Stahl, M., and Rarey, M. (2001). Detailed analysis of scoring functions for virtual screening. J Med Chem 44, 1035-1042.
117. Stigler, R. D., Hoffmann, B., Abagyan, R., and Schneider-Mergener, J. (1999). Soft docking an L and a D peptide to an anticholera toxin antibody using internal coordinate mechanics. Structure Fold Des 7, 663-670.
118. Subhash, S. (1996). Cluster analysis. In Applied Multivariate Techniques. New York: JohnWiley & Sons.
119. Taylor, R., (1995). Simulation analysis of experimental design strategies for screening random compounds as potential new drugs and agrochemicals. J Chem Inf Comput Sci 35, 59-67.
120. Terp, G., Johansen, B., Christensen, T., and Jørgensen, F. (2004). A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities. J Med Chem 44, 2333-2343.
121. Todeschini, R., and Consonni, V. (2000). Handbook of Molecular Descriptors, Weinheim, Germany: Wiley-VCH.
122. Toledo, L. M., Lydon, N. B., and Elbaum, D. (1999). The structure-based design of ATP-site directed protein kinase inhibitors. Curr Med Chem 6, 775-805.
123. Tong, L., Pav, S., White, D. M., Rogers, S., Crane, K. M., Cywin, C. L., Brown, M. L., and Pargellis, C. A. (1997). A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol 4, 311-316.
124. Trepalin, S. V., Gerasimenko, V. A., Kozyukov, A. V., Savchuk, N. P., and Ivaschenko, A. A. (2002). New diversity calculations algorithms used for compound selection. J Chem Inf Comput Sci 42, 249-258.
125. Venkatesh, S., and Lipper, R. A. (2000). Role of the development scientist in compound lead selection and optimization. J Pharm Sci 89, 145-154.
126. Verdonk, M., Berdini, V., Hartshorn, M., Mooij, W., Murray, C., Taylor, M., and Watson, P. (2004). Virtual screening using protein-ligand docking: avoiding artificial enrichment. J Chem Inf Comput Sci 44, 793-806.
127. Walters,W. P., and Murcko, M. A. (2002). Prediction of 'drug-likeness'. Adv Drug Deliv Rev 54, 255-271.
128. Walters, W. P., and Namchuk, M. (2003). Designing screens: How to make your hits a hit. Nat Rev Drug Discov 2, 259-266.
129. Wang, R., Lu, Y., and Wang, S. (2003). Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem 46, 2287-2003.
130. Willett, P. (2000). Chemoinformatics-Similarity and diversity in chemical libraries. Curr Opin Biotech 11, 85-88.
131. Willett, P., Barnard, J. M., and Downs, G. M. (1998). Chemical similarity searching. J Chem Inf Comput Sci 38, 983-996.
132. Xu, J., and Stevenson, J. (2000). Drug-like index: A new approach to measure drug-like compounds and their diversity. J Chem Inf Comput Sci 40, 1177-1187.
133. Xue, L., Stahura, F. L., Godden, J.W., and Bajorath, J. (2001). Fingerprint scaling increases the probability of identifying molecules with similar activity in virtual screening calculations. J Chem Inf Comput Sci 41, 746-753.
134. Xue, L., Godden, J.W., Stahura, F. L., and Bajorath, J. (2003). Profile scaling increases the similarity search performance of molecular fingerprints containing numerical descriptors and structural keys. J Chem Inf Comput Sci 43, 1218-1225.
135. Xue, L., Stahura, F. L., and Bajorath, J. (2004). Similarity search profiling reveals effects of fingerprint scaling in virtual screening. J Chem Inf Comput Sci 44, 2032-2039.
136. Young, S. S., and Ge, N. (2004). Design of diversity and focused combinatorial libraries in drug discovery. Curr Opin Drug Discov Devel 7, 318-324.
137. Yuta, K., and Jurs, P. C. (1981). Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines. J Med Chem 24, 241-251.
138. Zhorov, B. S., Folkman, E. V., and Ananthanarayanan, V. S. (2001). Homology model of dihydropyridine receptor: Implications for L-type Ca(2+) channel modulation by agonists and antagonists. Arch Biochem Biophys 393, 22-41.